Synonyms:bezafibrate, 41859-67-0, Bezalip, Cedur, Bezafibrat, Difaterol, Befizal, Azufibrat, Sklerofibrat, Bezafibrato, Bezafibratum, Bezatol, Bezafibratum [INN-Latin], Bezafibrato [INN-Spanish], Bezatol SR, BM-15.075, Bezatol SR (TN), 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid, BM 15.075, 2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid, BM-15075, NSC-758174, 2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]-2-methylpropanoic acid, BM15075, Propanoic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl-, MLS000028533, CHEMBL264374, durabezur, Reducterol, Bezabeta, Bezacur, Bezamerck, DTXSID3029869, Eulitop, Solibay, CHEBI:47612, Lipox, Bezafibrat PB, Y9449Q51XH, Beza-Lande, Beza-Puren, Regadrin B, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-propanoic acid, Propanoic acid, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-, NCGC00016850-01, SMR000058298, Bezafibrate 100 microg/mL in Acetonitrile, Bezafibrato [Spanish], 2-(4-(2-(4-Chlorobenzamido)ethyl)phenoxy)-2-methylpropanoic acid, Bezalip Retard, CAS-41859-67-0, 2-(4-{2-[(4-chlorophenyl)formamido]ethyl}phenoxy)-2-methylpropanoic acid, DTXCID909869, 1219802-74-0, LO 44, 2-(4-{2-[(4-chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic acid, 2-[P-[2-P-CHLOROBENZAMIDO)ETHYL]PHENOXY]-2-METHYLPROPIONIC ACID, BF-759, CCRIS 9085, BM 15075, SR-01000000106, EINECS 255-567-9, BRN 4267656, UNII-Y9449Q51XH, 2-{4-[2-(4-chlorobenzamido)ethyl]phenoxy}-2-methylpropanoic acid, Bezalip SR, Bezafibrate,(S), Bezafibrate [USAN:INN:BAN:JAN], PEM, Prestwick_724, MFCD00078970, BENAFIBRATE, Spectrum_001443, Opera_ID_376, BEZAFIBRATE [MI], Prestwick0_000378, Prestwick1_000378, Prestwick2_000378, Prestwick3_000378, Spectrum2_000922, Spectrum3_001500, Spectrum4_000325, Spectrum5_001079, Spectrum5_001967, BEZAFIBRATE [INN], BEZAFIBRATE [JAN], BEZAFIBRATE [USAN], BEZAFIBRATE [MART.], SCHEMBL16299, BEZAFIBRATE [WHO-DD], BSPBio_000535, BSPBio_001314, BSPBio_003119, KBioGR_000034, KBioGR_000669, KBioSS_000034, KBioSS_001923, MLS001148205, Bezafibrate, >=98%, solid, DivK1c_000092, SPECTRUM1502046, SPBio_000824, SPBio_002456, BPBio1_000589, GTPL2668, BDBM28701, Bezafibrate (JP17/USAN/INN), HMS500E14, KBio1_000092, KBio2_000034, KBio2_001923, KBio2_002602, KBio2_004491, KBio2_005170, KBio2_007059, KBio3_000067, KBio3_000068, KBio3_002619, 2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]isobutyric Acid, NINDS_000092, BEZAFIBRATE [EP MONOGRAPH], Bio2_000034, Bio2_000514, HMS1361B16, HMS1569K17, HMS1791B16, HMS1921H16, HMS1989B16, HMS2089F04, HMS2092B12, HMS2096K17, HMS2233E22, HMS3261D21, HMS3369B13, HMS3402B16, HMS3650K22, HMS3652M22, HMS3713K17, Pharmakon1600-01502046, BCP03700, HY-B0637, Tox21_110645, Tox21_301845, Tox21_500500, CCG-39683, NSC758174, s4159, AKOS005107743, Propionic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl-, Tox21_110645_1, AB03023, AC-6817, BCP9000398, DB01393, HS-0040, LP00500, NSC 758174, SB17361, SDCCGSBI-0051715.P003, IDI1_000092, IDI1_033784, NCGC00016850-02, NCGC00016850-03, NCGC00016850-04, NCGC00016850-05, NCGC00016850-06, NCGC00016850-07, NCGC00016850-08, NCGC00016850-09, NCGC00016850-10, NCGC00016850-11, NCGC00016850-12, NCGC00016850-15, NCGC00016850-25, NCGC00023317-03, NCGC00023317-04, NCGC00023317-05, NCGC00023317-06, NCGC00023317-07, NCGC00023317-08, NCGC00255376-01, NCGC00261185-01, BB166159, Bezafibrate, analytical reference material, BCP0726000153, SBI-0051715.P002, 2-(4-(2-(4-chlorobenzamido)ethyl)phenoxy), AB00052265, B3346, FT-0622617, SW196871-4, D01366, D70191, AB00052265-15, AB00052265_16, AB00052265_17, EN300-18539646, Q577387, SR-01000000106-3, SR-01000000106-4, SR-01000000106-5, W-106291, BRD-K46018455-001-06-0, BRD-K46018455-001-17-7, SR-01000000106-10, Bezafibrate, European Pharmacopoeia (EP) Reference Standard, 2-(4-(2-parachlorobenzamidoethyl)phenoxy)-2-methylpropionic acid, 2-[4-[2-(4-chlorobezamide)ethyl]phenoxy]-2-methylpropanoic acid, BF; 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl propanoic acid
Pubchem:PUBCHEM:39042
Id:5c6f5829-7a67-5278-bde2-76cf6f5747f3
Description:nan
